ROLE OF PROGESTERONE RECEPTOR RATIO IN BREAST CANCER
孕酮受体比率在乳腺癌中的作用
基本信息
- 批准号:6633941
- 负责人:
- 金额:$ 4.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-01 至
- 项目状态:未结题
- 来源:
- 关键词:breast neoplasms cell line ecdysone enhancer binding protein female genetic promoter element hormone regulation /control mechanism hormone related neoplasm /cancer integrins luciferin monooxygenase oncoproteins progesterone progesterone receptors protein isoforms receptor expression site directed mutagenesis transcription factor
项目摘要
Progesterone is a key reproductive hormone that binds to intranuclear progesterone receptors (PRs) which regulate transcription. There are two PR isoforms, PR-A and PR-B, that have very different biological effects. Both isoforms are coexpressed in breast cancers. Hypothesis:the effects of progesterone in breast cancers are influenced the A:B ratio present in the tumor. Aim 1. To construct breast cancer cell lines in which the PR-A to PR-B ratio can be varied, and to study progesterone regulation of endogenous C/EBPbeta, Stat5a and bcl-xL genes as the PR isoform ratio is varied. T47D Breast cancer cell lines in which one PR isoform is fixed, and the other can be varied from low to high levels will be created using the ecdysone inducible system to control the A:B ratio. These cells will be used to study endogenous expression of three genes differentially regulated by the two PRs: C/EBPbeta and Stat5a, which are regulated by PR-B but not PR-A, and bcl-xL, which is regulated by PR-A but not PR- B. These studies represent the first attempt to understand how the A:B ratio regulates expression of endogenous, progesterone-regulated genes. Aim 2. To elucidate the mechanisms by which PRA and PR-B differentially regulate target genes, by cloning and characterizing the promoters of three genes differentially regulated by the PR isoforms. The hypothesis that the structure of the promoters of C/EBPbeta, Stat5a and bcl-xL is responsible for their differential regulation by PR-A or PR-B will be tested by cloning the promoters of these genes. The promoter fragments will be subcloned into luciferase reporter vectors which will be transiently transfected into cells expressing only PR-A or PR-B to study their regulation. The cis-acting PR-regulated elements will be mapped by mutagenesis. These studies represent the first attempts to determine whether promoter-specific factors explain differential transcriptional regulation by PR-A vs. PR-B. Since PRs are prognostic indicators in breast cancer, these studies may require revision of clinical assays to include measurement of the two isoforms.
孕酮是一种关键的生殖激素,与调节转录的核内孕酮受体(PR)结合。PR有两种亚型,PR-A和PR-B,具有非常不同的生物学效应。这两种亚型在乳腺癌中共表达。假设:孕激素在乳腺癌中的作用受到肿瘤中A:B比例的影响。目标1。构建PR-A/PR-B比值可变的乳腺癌细胞系,研究孕激素对内源性C/EBP β、Stat 5a和bcl-xL基因的调节作用。T47 D使用蜕皮激素诱导系统控制A:B比率,将产生其中一种PR同种型固定而另一种可从低水平变化到高水平的乳腺癌细胞系。这些细胞将用于研究由两种PR差异调节的三种基因的内源性表达:C/EBP β和Stat 5a,其由PR-B调节但不受PR-A调节,以及bcl-xL,其由PR-A调节但不受PR- B调节。这些研究代表了第一次试图了解A:B比例如何调节内源性胆固醇调节基因的表达。 目标二。通过克隆和鉴定三个受PR异构体差异调节的基因的启动子,阐明PRA和PR-B差异调节靶基因的机制。将通过克隆这些基因的启动子来测试C/EBP β、Stat 5a和bcl-xL的启动子的结构负责PR-A或PR-B对它们的差异调节的假设。将启动子片段亚克隆到荧光素酶报告载体中,将其瞬时转染到仅表达PR-A或PR-B的细胞中以研究其调节。顺式作用PR调节元件将通过诱变作图。这些研究代表了第一次尝试,以确定是否启动子特异性因子解释差异转录调节PR-A与PR-B。由于PR是乳腺癌的预后指标,这些研究可能需要修改临床测定,以包括两种亚型的测量。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Partial loss of the DNA repair scaffolding protein, Xrcc1, results in increased brain damage and reduced recovery from ischemic stroke in mice.
DNA修复脚手架蛋白的部分丢失XRCC1导致脑损伤增加并减少小鼠缺血性中风的恢复。
- DOI:10.1016/j.neurobiolaging.2015.04.004
- 发表时间:2015-07
- 期刊:
- 影响因子:4.2
- 作者:Ghosh S;Canugovi C;Yoon JS;Wilson DM 3rd;Croteau DL;Mattson MP;Bohr VA
- 通讯作者:Bohr VA
Do structural changes in GABA neurons give rise to the epileptic state?
- DOI:10.1007/978-94-017-8914-1_12
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Houser CR
- 通讯作者:Houser CR
Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination.
- DOI:10.1093/jnen/nlab083
- 发表时间:2021-10-26
- 期刊:
- 影响因子:3.2
- 作者:Prineas JW;Parratt JDE
- 通讯作者:Parratt JDE
Microglia subtypes in acute, subacute, and chronic multiple sclerosis.
- DOI:10.1093/jnen/nlad046
- 发表时间:2023-07-20
- 期刊:
- 影响因子:3.2
- 作者:
- 通讯作者:
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain.
- DOI:10.1038/s41537-022-00231-1
- 发表时间:2022-02-25
- 期刊:
- 影响因子:0
- 作者:De Rosa A;Fontana A;Nuzzo T;Garofalo M;Di Maio A;Punzo D;Copetti M;Bertolino A;Errico F;Rampino A;de Bartolomeis A;Usiello A
- 通讯作者:Usiello A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRITTA M JACOBSEN其他文献
BRITTA M JACOBSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRITTA M JACOBSEN', 18)}}的其他基金
ROLE OF PROGESTERONE RECEPTOR RATIO IN BREAST CANCER
孕酮受体比率在乳腺癌中的作用
- 批准号:
6514915 - 财政年份:2002
- 资助金额:
$ 4.81万 - 项目类别:
ROLE OF PROGESTERONE RECEPTOR RATIO IN BREAST CANCER
孕酮受体比率在乳腺癌中的作用
- 批准号:
6298512 - 财政年份:2001
- 资助金额:
$ 4.81万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 4.81万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 4.81万 - 项目类别:
Studentship